| 24 May 2026 |
DHB (1-Test Cyp) Oral |
9.4 |
10mg |
9.2mg |
-8.1% |
96.92% |
Lab G |
| 24 May 2026 |
Tamoxifen (Nolvadex) |
10.0 |
100mg |
101.7mg |
+1.7% |
99.98% |
Lab B |
| 24 May 2026 |
AICAR |
5.3 |
10mg |
8.5mg |
-14.6% |
97.12% |
Lab F |
| 24 May 2026 |
Chonluten |
10.0 |
2mg |
1.8mg |
-7.9% |
98.03% |
Lab E |
| 24 May 2026 |
Dianabol |
8.8 |
100mg |
94.4mg |
-5.6% |
98.58% |
Lab A |
| 24 May 2026 |
NAD+ |
10.0 |
5mg |
5.8mg |
+16.0% |
99.17% |
Lab B |
| 24 May 2026 |
Proviron (Mesterolone) |
10.0 |
50mg |
54.5mg |
+8.9% |
99.03% |
Lab C |
| 24 May 2026 |
Retatrutide |
8.9 |
30mg |
32.4mg |
+8.0% |
99.85% |
Lab E |
| 24 May 2026 |
EPO |
9.8 |
2mg |
2.2mg |
+8.6% |
97.24% |
Lab F |
| 24 May 2026 |
Retatrutide |
7.8 |
10mg |
9.9mg |
-1.0% |
99.80% |
Lab G |
| 23 May 2026 |
Thymalin |
6.1 |
20mg |
23.8mg |
+18.8% |
96.45% |
Lab A |
| 21 May 2026 |
BPC-157 Capsule |
8.1 |
20mg |
18.5mg |
-7.7% |
97.07% |
Lab D |
| 21 May 2026 |
Lipo-B 216mg |
8.3 |
300mg/ml |
347.3mg/ml |
+15.8% |
99.58% |
Lab G |
| 19 May 2026 |
Retatrutide |
6.0 |
10mg |
11.2mg |
+12.0% |
99.90% |
Lab E |
| 19 May 2026 |
Retatrutide |
8.0 |
10mg |
10mg |
|
99.90% |
Lab E |
| 19 May 2026 |
Retatrutide |
8.0 |
60mg |
62.7mg |
+4.5% |
99.90% |
Lab G |
| 19 May 2026 |
Ostarine (MK-2866) |
6.0 |
50mg |
48.8mg |
-2.5% |
95.71% |
Lab E |
| 17 May 2026 |
5-amino-1MQ |
7.2 |
30mg |
36.3mg |
+21.0% |
97.75% |
Lab D |
| 17 May 2026 |
Nitroethane CAS 79-24-3 |
9.4 |
500g |
571.8g |
+14.4% |
97.71% |
Lab D |
| 17 May 2026 |
Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) |
7.7 |
300mg/ml |
362.3mg/ml |
+20.8% |
96.25% |
Lab B |
| 29 Jan 2026 |
Retatrutide |
6.6 |
10mg |
10.2mg |
+2.0% |
99.32% |
Lab E |
| 29 Jan 2026 |
TriTren 225 |
7.9 |
200mg/ml |
193.8mg/ml |
-3.1% |
98.91% |
Lab E |
| 26 Jan 2026 |
Retatrutide |
7.8 |
20mg |
20.4mg |
+2.0% |
99.80% |
Lab E |
| 26 Jan 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
10.0 |
2mg |
2.3mg |
+14.9% |
98.49% |
Lab D |
| 26 Jan 2026 |
GHRP-6 Acetate |
8.5 |
20mg |
21.5mg |
+7.4% |
97.16% |
Lab G |
| 26 Jan 2026 |
Testosterone Phenylpropionate Raw |
7.2 |
1g |
1.2g |
+16.5% |
95.79% |
Lab C |
| 9 Jan 2026 |
DSIP |
7.0 |
2mg |
1.8mg |
-8.8% |
97.05% |
Lab A |
| 7 Jan 2026 |
Liraglutide |
4.9 |
20mg |
19.3mg |
-3.5% |
99.90% |
Lab B |
| 7 Jan 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
7.3 |
10mg |
9.4mg |
-5.6% |
99.98% |
Lab G |
| 7 Jan 2026 |
Primobolan E |
5.0 |
100mg/ml |
102.5mg/ml |
+2.5% |
96.41% |
Lab G |
| 7 Jan 2026 |
Testosterone Decanoate Raw |
5.7 |
1g |
1.1g |
+11.7% |
99.64% |
Lab F |
| 6 Jan 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
5.2 |
15mg |
15.3mg |
+1.7% |
98.03% |
Lab A |
| 29 Dec 2025 |
Test Suspension |
8.4 |
200mg/ml |
222.2mg/ml |
+11.1% |
95.65% |
Lab E |
| 12 Dec 2025 |
IGF-1 LR3 |
9.4 |
2mg |
2.0mg |
-1.6% |
98.91% |
Lab F |
| 5 Dec 2025 |
N-Acetyl Epitalon Amidate |
6.0 |
5mg |
4.3mg |
-14.2% |
97.92% |
Lab B |
| 5 Dec 2025 |
Primobolan Oral (Methenolone Acetate) |
7.9 |
20mg |
23.1mg |
+15.3% |
99.81% |
Lab C |
| 17 Oct 2025 |
Selank |
6.0 |
2mg |
2.3mg |
+12.9% |
96.21% |
Lab F |
| 3 Oct 2025 |
BPC157 5mg + TB500 5mg Blend |
7.3 |
10mg |
9.3mg |
-6.6% |
96.88% |
Lab C |
| 3 Oct 2025 |
GHRP-2 Acetate |
9.0 |
15mg |
12.8mg |
-14.5% |
95.73% |
Lab G |
| 3 Oct 2025 |
SNAP-8 |
6.1 |
5mg |
5.7mg |
+14.2% |
95.48% |
Lab F |